Engineered Nanocrystal Technology: in-vivo fate, targeting and applications in drug delivery

Show simple item record

dc.contributor.author Pawar, V K
dc.contributor.author Singh, Yuvraj
dc.contributor.author Meher, J G
dc.contributor.author Gupta, Siddharth
dc.contributor.author Chourasia, M K
dc.date.accessioned 2014-08-11T05:51:17Z
dc.date.available 2014-08-11T05:51:17Z
dc.date.issued 2014
dc.identifier.citation Journal of Controlled Release. 2014, 183, 51-66 en
dc.identifier.uri http://hdl.handle.net/123456789/1349
dc.description.abstract Formulation of nanocrystals is a robust approach which can improve delivery of poorly water soluble drugs, a challenge pharmaceutical industry has been facing since long. Large scale production of nanocrystals is done by techniques like precipitation, media milling and, high pressure homogenization. Application of stabilizers along with drying accords nanocrystals long term stability and commercial viability. These can be administered through oral, parenteral, pulmonary, dermal and ocular routes showing their high therapeutic applicability. They serve to target drug molecules in specific regions through size manipulation and surface modification. This review dwells upon the in-vivo fate and varying applications in addition to the facets of drug nanocrystals stated above. en
dc.format.extent 882789 bytes
dc.format.mimetype application/pdf
dc.language.iso en en
dc.relation.ispartofseries CSIR-CDRI Communication No. 8640 en
dc.subject Nanocrystals en
dc.subject Poorly Soluble Drugs en
dc.subject In-Vivo Fate en
dc.subject Bioavailability en
dc.subject Stability en
dc.subject Targeted Delivery en
dc.title Engineered Nanocrystal Technology: in-vivo fate, targeting and applications in drug delivery en
dc.type Article en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account